Emerging therapeutic approaches of SHP2-targeted modulators
Tweetable abstract Monotherapy and combination therapy of SHP2 regulator for cancer treatment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Future medicinal chemistry - 16(2024), 4 vom: 06. Feb., Seite 291-294 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yang, Xinyu [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 07.02.2024 Date Revised 07.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/fmc-2023-0348 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367655667 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367655667 | ||
| 003 | DE-627 | ||
| 005 | 20240207232257.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240126s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/fmc-2023-0348 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1283.xml |
| 035 | |a (DE-627)NLM367655667 | ||
| 035 | |a (NLM)38275153 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yang, Xinyu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Emerging therapeutic approaches of SHP2-targeted modulators |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.02.2024 | ||
| 500 | |a Date Revised 07.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Tweetable abstract Monotherapy and combination therapy of SHP2 regulator for cancer treatment | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a SHP2 modulator | |
| 650 | 4 | |a combination therapy | |
| 650 | 4 | |a epigenetic inhibitors | |
| 650 | 4 | |a immune checkpoint blockers | |
| 650 | 4 | |a kinase inhibitors | |
| 650 | 4 | |a protein tyrosine phosphatases | |
| 650 | 7 | |a Protein Tyrosine Phosphatase, Non-Receptor Type 11 |2 NLM | |
| 650 | 7 | |a EC 3.1.3.48 |2 NLM | |
| 700 | 1 | |a Xiong, Jinbo |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Bin |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Yihui |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 16(2024), 4 vom: 06. Feb., Seite 291-294 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2024 |g number:4 |g day:06 |g month:02 |g pages:291-294 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2023-0348 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2024 |e 4 |b 06 |c 02 |h 291-294 | ||